ATLAS / Macro Radar / Reporting / KYTX

Kyverna Therapeutics, Inc. (KYTX) reporting calendar

Kyverna Therapeutics, Inc. files periodic reports with the SEC as KYTX on Nasdaq. Atlas tracks 10 filed reports for this issuer, each linked to its original EDGAR accession.

Next window
21 Jul 2026 – 3 Sep 2026
Latest report
10-Q
Period ended
31 Mar 2026
Filed
12 May 2026
Reports on record
10

How this window is derived. Derived from this issuer's own filing history: 9 periods at a median 91-day cadence, filed a median 43 days after period end. The SEC does not publish forward reporting dates and Atlas does not estimate one.

Open KYTX market profile Latest filing on SEC EDGAR ↗ Biological Products, (No Diagnostic Substances) reporting datesAll Nasdaq reporting dates

Filed periodic reports

FormPeriod endedFiledLagSEC accession
10-Q31 Mar 202612 May 202642 days0001193125-26-219397
10-K31 Dec 202526 Mar 202685 days0001193125-26-126242
10-Q30 Sep 202512 Nov 202543 days0001193125-25-277584
10-Q30 Jun 202512 Aug 202543 days0000950170-25-107321
10-Q31 Mar 202513 May 202543 days0000950170-25-070325
10-K31 Dec 202427 Mar 202586 days0000950170-25-046074
10-Q30 Sep 202413 Nov 202444 days0000950170-24-126366
10-Q30 Jun 202412 Aug 202443 days0000950170-24-095462
10-Q31 Mar 202414 May 202444 days0000950170-24-059628
10-K31 Dec 202326 Mar 202486 days0000950170-24-036481

Source: SEC EDGAR company submissions for CIK 0001994702. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.